Carrie Morris, MD
Ophthalmic Plastic and Reconstructive Surgery · Gulf Shores, ALNPI 1437294063
Payments from drug & device makers
Across 32 payments — averaging $695.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$22K
- Exeltis, USA Inc.$97
- Boston Scientific$73
- Galderma Laboratories, L.p.$70
- Scynexis, Inc.$45
- Revance Therapeutics, Inc.$35
- plus $120 from 5 others
What the payments were for
- Food & beverage$7854%
- Gifts$21,46996%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $21,815 |
| Exeltis, USA Inc. | 6 | $97 |
| Boston Scientific | 3 | $73 |
| Galderma Laboratories, L.p. | 4 | $70 |
| Scynexis, Inc. | 3 | $45 |
| Revance Therapeutics, Inc. | 2 | $35 |
| Amgen | 2 | $35 |
| Sight Sciences, Inc. | 1 | $24 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $24 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
How this compares
Too few ophthalmic plastic and reconstructive surgery providers in Alabamato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 21 | $1,565 |
| ErythromycinErythromycin Base | 39 | $422 |
| Ciprofloxacin Hcl | 26 | $411 |
| ValacyclovirValacyclovir Hcl | 20 | $133 |
| Methylprednisolone | 16 | $104 |
Paid to pharmacies, not to this prescriber.
Other ophthalmic plastic and reconstructive surgery in Gulf Shores
- Mark BrownMobile$42K
- Matthew VicinanzoBirmingham$1K
- John LongBirmingham$742
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.